ArticleJournal of healthcare engineering2022
Metaheuristics with Deep Learning-Enabled Parkinson's Disease Diagnosis and Classification Model.
Article in Journal of healthcare engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 20 citations in OpenAlex.
- A quantum-classical dual-track deep learning network for explainable Parkinson's disease classification.Frontiers in artificial intelligence · 2026Article
- Applications of Artificial Intelligence in Neurological Voice Disorders.World journal of otorhinolaryngology - head and neck surgery · 2025Review
- A deep learning model for detection of leukocytes under various interference factors.Scientific reports · 2023Article
- A penalty-based algorithm proposal for engineering optimization problems.Neural computing & applications · 2023Article
- OEDL: an optimized ensemble deep learning method for the prediction of acute ischemic stroke prognoses using union features.Frontiers in neurology · 2023Article
- Optimal Deep Learning-Based Vocal Fold Disorder Detection and Classification Model on High-Speed Video Endoscopy.Journal of healthcare engineering · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) affects the movement of people, including the differences in writing skill, speech, tremor, and stiffness in muscles. It is significant to detect the PD at the initial stages so that the person can live a peaceful life for a longer time period. The serious levels of PD are highly risky as the patients get progressive stiffness, which results in the inability of standing or walking. Earlier studies have focused on the detection of PD effectively using voice and speech exams and writing exams. In this aspect, this study presents an improved sailfish optimization algorithm with deep learning (ISFO-DL) model for PD diagnosis and classification. The presented ISFO-DL technique uses the ISFO algorithm and DL model to determine PD and thereby enhances the survival rate of the person. The presented ISFO is a metaheuristic algorithm, which is inspired by a group of hunting sailfish to determine the optimum solution to the problem. Primarily, the ISFO algorithm is applied to derive an optimal subset of features with a fitness function of maximum classification accuracy. At the same time, the rat swarm optimizer (RSO) with the bidirectional gated recurrent unit (BiGRU) is employed as a classifier to determine the existence of PD. The performance validation of the IFSO-DL model takes place using a benchmark Parkinson's dataset, and the results are inspected under several dimensions. The experimental results highlighted the enhanced classification performance of the ISFO-DL technique, and therefore, the proposed model can be employed for the earlier identification of PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.